Das ist der Job
The IOSI has a dedicated Phase 1 Unit where early phase clinical trials, including first‑in‑human, are conducted.
Darum lohnt es sich
About the IOSIThe Oncology Institute of Southern Switzerland (IOSI) is one of the largest clinical research centers in Switzerland. Our three main areas of clinical research comprise new drug development, lymphoproliferative diseases and prostate cancer.
We collaborate with academic organisations and the pharmaceutical industry, including the Institute of Oncology Research, the Institute of Biochemical Research and the Swiss Cancer Institute.Position OverviewSenior Staff Physician with expertise in drug development and early-phase clinical trials in oncology.Key ResponsibilitiesClinical activities within a selected disease group can also be considered, aligned with the candidate’s areas of expertise.QualificationsMedical degree and completed specialist training in Medical Oncology.For candidates holding foreign qualifications, recognition by the Swiss Federal Commission for Medical Professions (MEBEKO) is mandatory.
The qualification must be equivalent to the Swiss standard; however, recognition may be obtained after acceptance of the position.
Registration in MedReg is also required, including proof of proficiency in one or more Swiss official languages (Italian, German, or French).Proficiency in both Italian and English.Previous experience in early-phase clinical trials in oncology; at least 2–3 years of experience in a Phase I Unit is highly desirable.Strong interest in and commitment to contributing to the clinical and research activities of the Phase I Unit at the IOSI.Enthusiasm for actively supporting the growth and development of our Phase 1 Unit.Availability to support and supervise residents and clinical fellows as part of the Institute’s educational and training activities.Excellent interpersonal and communication skills, with the ability to work effectively in a multidisciplinary and research‑oriented environment.Demonstrated initiative, flexibility, organisational skills, and a collaborative approach to interdisciplinary and translational research activities.Candidates who do not yet hold a specialist title in Medical Oncology are not eligible for this position.TimelineThe entry date is expected from September 2026, but we are flexible and an individual start date can also be considered. #J-18808-Ljbffr
